Extending Combination Therapy with Peginterferon plus Ribavirin for Genotype 2 Chronic Hepatitis C Virological Responders: A Pilot Study of 7 Cases | Zendy

Norio Akuta | Zendy; Fumitaka Suzuki | Zendy; Yasuji Arase | Zendy; Miharu Hirakawa | Zendy; Yusuke Kawamura | Zendy; Hiromi Yatsuji | Zendy; Hitomi Sezaki | Zendy; Yoshiyuki Suzuki | Zendy; Tetsuya Hosaka | Zendy; Masahiro Kobayashi | Zendy; Mariko Kobayashi | Zendy; Satoshi Saitoh | Zendy; Kenji Ikeda | Zendy; Hiromitsu Kumada | Zendy

Open Access

Extending Combination Therapy with Peginterferon plus Ribavirin for Genotype 2 Chronic Hepatitis C Virological Responders: A Pilot Study of 7 Cases

Author(s) -

Norio Akuta,

Fumitaka Suzuki,

Yasuji Arase,

Miharu Hirakawa,

Yusuke Kawamura,

Hiromi Yatsuji,

Hitomi Sezaki,

Yoshiyuki Suzuki,

Tetsuya Hosaka,

Masahiro Kobayashi,

Mariko Kobayashi,

Satoshi Saitoh,

Kenji Ikeda,

Hiromitsu Kumada

Publication year - 2010

Publication title -

intervirology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.641

H-Index - 61

eISSN - 1423-0100

pISSN - 0300-5526

DOI - 10.1159/000289343

Subject(s) - ribavirin , medicine , genotype , chronic hepatitis , gastroenterology , combination therapy , antiviral therapy , viral load , immunology , virus , gene , biology , biochemistry

In treatment-resistant patients with genotype 2 chronic hepatitis C the suitable treatment duration is still unclear. The aims were to investigate extending combination therapy with peginterferon plus ribavirin for genotype 2.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research